PT80375B - N-3-DISSUBSTITUATED, UTEIS 2-OXIDOLE-1-CARBOXAMIDES AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS - Google Patents

N-3-DISSUBSTITUATED, UTEIS 2-OXIDOLE-1-CARBOXAMIDES AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS

Info

Publication number
PT80375B
PT80375B PT80375A PT8037585A PT80375B PT 80375 B PT80375 B PT 80375B PT 80375 A PT80375 A PT 80375A PT 8037585 A PT8037585 A PT 8037585A PT 80375 B PT80375 B PT 80375B
Authority
PT
Portugal
Prior art keywords
oxidole
dissubstituated
uteis
carboxamides
analgesic
Prior art date
Application number
PT80375A
Other languages
Portuguese (pt)
Other versions
PT80375A (en
Inventor
Saul Bernard Kadin
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT80375A publication Critical patent/PT80375A/en
Publication of PT80375B publication Critical patent/PT80375B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT80375A 1984-05-04 1985-04-30 N-3-DISSUBSTITUATED, UTEIS 2-OXIDOLE-1-CARBOXAMIDES AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS PT80375B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (2)

Publication Number Publication Date
PT80375A PT80375A (en) 1985-05-01
PT80375B true PT80375B (en) 1987-09-30

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
PT80375A PT80375B (en) 1984-05-04 1985-04-30 N-3-DISSUBSTITUATED, UTEIS 2-OXIDOLE-1-CARBOXAMIDES AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS

Country Status (25)

Country Link
JP (1) JPS60243068A (en)
KR (1) KR870000497B1 (en)
AR (1) AR241159A1 (en)
BG (2) BG60208B2 (en)
CS (1) CS252828B2 (en)
DD (1) DD232916A5 (en)
EG (1) EG17193A (en)
ES (2) ES8609248A1 (en)
FI (1) FI80016C (en)
HU (1) HU196057B (en)
IE (1) IE851103L (en)
IN (1) IN161509B (en)
MA (1) MA20424A1 (en)
MW (1) MW1685A1 (en)
MX (1) MX5839A (en)
NO (1) NO163132C (en)
OA (1) OA08098A (en)
PL (2) PL145416B1 (en)
PT (1) PT80375B (en)
RO (2) RO94455B (en)
RU (1) RU2017729C1 (en)
SU (1) SU1468413A3 (en)
YU (1) YU44998B (en)
ZA (1) ZA853324B (en)
ZW (1) ZW7885A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-substituted-2-oxindole derivatives for the preparation of a pharmaceutical preparation for inhibiting interleukin-1 biosynthesis

Also Published As

Publication number Publication date
MA20424A1 (en) 1985-12-31
PL145416B1 (en) 1988-09-30
ZW7885A1 (en) 1985-07-24
OA08098A (en) 1987-03-31
KR850008154A (en) 1985-12-13
RU2017729C1 (en) 1994-08-15
NO163132C (en) 1990-04-11
PL257892A1 (en) 1986-10-07
RO94455B (en) 1988-07-01
AR241159A2 (en) 1991-12-30
FI80016C (en) 1990-04-10
IE851103L (en) 1985-11-04
RO94455A (en) 1988-06-30
ES551275A0 (en) 1987-07-16
IN161509B (en) 1987-12-19
BG60208B2 (en) 1993-12-30
FI851756L (en) 1985-11-05
DD232916A5 (en) 1986-02-12
CS320285A2 (en) 1987-03-12
YU44998B (en) 1991-06-30
RO91141A (en) 1987-06-30
AR241159A1 (en) 1991-12-30
ES8609248A1 (en) 1986-07-16
HU196057B (en) 1988-09-28
ES542813A0 (en) 1986-07-16
BG60207B2 (en) 1993-12-30
RO91141B (en) 1987-07-03
ZA853324B (en) 1986-12-30
JPS60243068A (en) 1985-12-03
MW1685A1 (en) 1986-09-10
YU73085A (en) 1988-04-30
NO851774L (en) 1985-11-05
CS252828B2 (en) 1987-10-15
KR870000497B1 (en) 1987-03-12
PL253203A1 (en) 1986-06-17
SU1468413A3 (en) 1989-03-23
EG17193A (en) 1990-08-30
PT80375A (en) 1985-05-01
HUT37754A (en) 1986-02-28
ES8707182A1 (en) 1987-07-16
MX5839A (en) 1993-11-01
JPH0335315B2 (en) 1991-05-27
PL147508B1 (en) 1989-06-30
FI851756A0 (en) 1985-05-03
NO163132B (en) 1990-01-02
FI80016B (en) 1989-12-29

Similar Documents

Publication Publication Date Title
BR8504814A (en) MASKING GUM COMPOSITION AND PROCESS TO PREPARE THE SAME
BR8500673A (en) PROCESS TO PREPARE PIRAZOL DERIVATIVES AND INSECTICID COMPOSITES BASED ON THE SAME
BR8603901A (en) PROCESS FOR THE PREPARATION OF 2-OXO-1,3-DIOXOLANS AND ITS USE
PT82891B (en) PROCESS FOR THE PREPARATION OF HEXAROCYCYCLICALLY SUBSTITUTED ISOXAZOIS AND HYDROXYLICKYL HYDROXYLICHYLS AS ANTI-VIRAL AGENTS
BR8606423A (en) MATRIX FOUNDATION PROCESS
BR8701335A (en) WELDING PROCESS
PT81393B (en) PROCESS FOR THE PREPARATION OF OXINDOLIC ANTI-INFLAMMATORY AGENTS
BR8505876A (en) PROCESS FOR OBTAINING HOMOPROPARGILAMINE AND PESTICIDE COMPOSITION
BR8505941A (en) PROCESS FOR THE PREPARATION OF MODIFIED ORGANIC POLYISOCIANATES, POLYISOCIANATES AND APPLICATION
IT1200095B (en) MAFTALENIC COMPOUNDS, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
ES293213Y (en) CABIN CONSTRUCTION FOR A MANUFACTURING LINE
BR8606668A (en) INCONTINENCE PROTECTOR AND PROCESS FOR MANUFACTURING THE SAME
BR8701136A (en) FOUNDATION NOZZLE AND PROCESS FOR THE SAME MANUFACTURE
BR8501129A (en) CATALYTIC DEPARING PROCESS
PT80375B (en) N-3-DISSUBSTITUATED, UTEIS 2-OXIDOLE-1-CARBOXAMIDES AS ANALGESIC AND ANTI-INFLAMMATORY AGENTS
PT83348B (en) N-SULFAMYL-3- (2-GUANIDINE-THIAZOL-4-IL-METHYLTHY) -PROPIONAMIDINE PREPARATION
BR8604209A (en) COMPOUND, PROCESS TO PREPARE IT AND PESTICIDE COMPOSITION
IT1206480B (en) NITRO ANTRACICLINE, PROCESS FOR THEIR PREPARATION AND USE.
BR8504150A (en) PROCESS FOR THE PREPARATION OF REPLACED ARYLSULPHONYGUANIDINES, HERBICIDIC COMPOSITIONS, APPLICATION AND PROCESS FOR THE PREPARATION OF COMPOSITIONS
BR8504148A (en) PROCESS FOR THE PREPARATION OF FLUORALCOXYPHENYLSULPHONYL-GUANIDINES, HERBICIDAL COMPOSITIONS, APPLICATION AND PROCESS FOR THE PREPARATION OF COMPOSITIONS
PT81140B (en) PROCESS FOR THE PREPARATION OF ANALGESIC AND ANTI-INFLAMMATORY 1,3-DIACYL-2-OXINDOLE COMPOUNDS
BR8502540A (en) PROCESS FOR OBTAINING AROMATIC COMPOUNDS, AROMATIC COMPOUNDS AND USE
IT1199949B (en) DIAZEPINOINDOLI, THEIR PREPARATION AND THEIR USE AS MEDICATIONS
PT81157B (en) PROCESS FOR THE PREPARATION OF AROMATIC-1,4-OXAZEPINONES AND TIONS
BR8704434A (en) PESTICIDE COMPOSITION, COMPOUND AND PROCESS TO OBTAIN THE SAME